Portfolio company
Barinthus Biotherapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops antigen-specific immunotherapies and vaccines to treat patients with chronic infectious diseases, autoimmunity and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Inimmune
The company develops immunotherapies and vaccine components to treat patients with allergies, cancer, infectious diseases and autoimmune conditions.
Cytos Biotechnology AG
This biopharmaceutical company develops immunotherapies and vaccines targeting chronic and infectious diseases for patients and healthcare providers.
Abacus Bioscience
This company develops active immunotherapies to treat cancer and chronic infections for patients requiring advanced medical treatments.
Silverback Therapeutics
This biopharmaceutical company develops immune-modulating therapeutics for patients with cancer and chronic viral infections.
Immunocore
This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.
